| 嘉南藥理大學 |
2009 |
Clinical Immunology Newsletter
|
Elsevier SDOL |
| 國立成功大學 |
2021 |
Clinical impact and risk factors of nonsusceptibility to third-generation cephalosporins among hospitalized adults with monomicrobial enterobacteriaceae bacteremia in southern Taiwan: A multicenter study
|
Lin, T.-C.;Hung, Y.-P.;Lee, C.-C.;Lin, W.-T.;Huang, L.-C.;Dai, W.;Kuo, C.-S.;Ko, W.-C.;Huang, Y.-L. |
| 國立臺灣大學 |
2002 |
Clinical Impact of (18)F Fdg-Pet in Patients with Suspected Recurrent Breast Cancer Based on Asymptomatically Elevated Tumor Marker Serum Levels : A Preliminary Report
|
顏若芳; YEN, RUOH-FANG |
| 臺大學術典藏 |
2018-09-10T07:24:09Z |
Clinical impact of 18F-FDG PET on the management of patients with early non-small-cell lung cancer by conventional workup.
|
RUOH-FANG YEN; RUOH-FANG YEN |
| 中國醫藥大學 |
2002-07 |
Clinical impact of 18F-FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels A preliminary report.
|
劉秋松(Liu,Chiu-Shong); (Yeh-You Shen); 林正介(Lin,Cheng-Chieh); (Ruoh-Fang Yan); 高嘉鴻(Kao,Chia-Hung)* |
| 國立成功大學 |
2012-07 |
Clinical impact of BI-RADS classification in Taiwanese breast cancer patients: BI-RADS 5 versus BI-RADS 0-4
|
Kuo, Yao-Lung; Cheng, Lili; Chang, Tsai-Wang |
| 國立成功大學 |
2021-02 |
Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemia
|
Lee;Nan-Yao;Lo;Ching-Lung;Chen;Po-Lin;Syue;Ling-Shan;Li;Chia-Wen;Li;Ming-Chi;Ko;Wen-Chien |
| 國家衛生研究院 |
2015-06 |
Clinical impact of Clostridium difficile colonization
|
Hung, YP;Lee, JC;Lin, HJ;Liu, HC;Wu, YH;Tsai, PJ;Ko, WC |
| 國立臺灣大學 |
2007 |
Clinical Impact of Gb Virus C Viremia on Patients with Hiv Type 1 Infection in the Era of Highly Active Antiretroviral Therapy
|
盛望徽; 洪健清; 王振泰; 陳培哲; 張上淳; 高嘉宏; SHENG, WANG-HUEI; HUNG, CHIEN-CHING; WANG, JANN-TAY; CHEN, PEI-JER; CHANG, SHAN-CHWEN; KAO, JIA-HORNG |
| 國立臺灣大學 |
2006-02 |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Sheng, WH (Sheng, Wang-Huei); Hung, CC (Hung, Chien-Ching); Wu, RJ (Wu, Ruei-Jiuan); Wang, JT (Wang, Jann-Tay); Chen, PJ (Chen, Pei-Jer); Chang, SC (C |
| 臺大學術典藏 |
2018-09-10T06:27:52Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
SHAN-CHWEN CHANG; JIA-HORNG KAO; JANN-TAY WANG; CHIEN-CHING HUNG; Sheng, W.-H. and Hung, C.-C. and Wu, R.-J. and Wang, J.-T. and Chen, P.-J. and Chang, S.-C. and Kao, J.-H.; PEI-JER CHEN; WANG-HUEI SHENG |
| 臺大學術典藏 |
2020-09-30T03:23:05Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Kao J.-H.; Chang S.-C.; Chen P.-J.; Wang J.-T.; Sheng W.-H.;Chien-Ching Hung;Wu R.-J.;Wang J.-T.;Chen P.-J.;Chang S.-C.;Kao J.-H.; Sheng W.-H.; CHIEN-CHING HUNG; Wu R.-J. |
| 臺大學術典藏 |
2020-12-29T03:08:52Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Sheng W.-H.;Hung C.-C.;Wu R.-J.;Jann-Tay Wang;Chen P.-J.;Chang S.-C.;Kao J.-H.; Kao J.-H.; Sheng W.-H.; Hung C.-C.; Wu R.-J.; JANN-TAY WANG; Chen P.-J.; Chang S.-C. |
| 臺大學術典藏 |
2007 |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Wang J.-T.; Wu R.-J.; Hung C.-C.; Sheng W.-H.; Chen P.-J.; SHAN-CHWEN CHANG; Kao J.-H. |
| 臺大學術典藏 |
2021-02-26T02:00:18Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Wang-Huei Sheng;Hung C.-C.;Wu R.-J.;Wang J.-T.;Chen P.-J.;Chang S.-C.;Kao J.-H.; WANG-HUEI SHENG; Hung C.-C.; Wu R.-J.; Wang J.-T.; Chen P.-J.; Chang S.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:35:07Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Sheng W.-H.; Hung C.-C.; Wu R.-J.; Wang J.-T.; PEI-JER CHEN; Chang S.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:42Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Sheng W.-H.; Hung C.-C.; Wu R.-J.; Wang J.-T.; Chen P.-J.; Chang S.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-05-13T08:05:08Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Sheng W.-H.; Hung C.-C.; Wu R.-J.; JANN-TAY WANG; Chen P.-J.; Chang S.-C.; Kao J.-H. |
| 國立臺灣大學 |
2007-11 |
Clinical impact of GB virus C viremia on patients with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy.
|
Sheng, WH; Hung, CC; Wang, RJ; Wang, JT; Chen, PJ; Chang, SC; Kao, JH. |
| 臺大學術典藏 |
2021-07-22T06:25:01Z |
Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma
|
CHIH-YANG HSIAO; Yang P.-C.; Li X.; Huang K.-W. |
| 臺大學術典藏 |
2021-04-29T06:52:42Z |
Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma
|
Hsiao, Chih-Yang;Yang, Po-Chih;Li, Xiaoyong;Kai-Wen Huang; Hsiao, Chih-Yang; Yang, Po-Chih; Li, Xiaoyong; KAI-WEN HUANG |
| 中山醫學大學 |
2020 |
Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib
|
Chen, YY; Wang, CC; Liu, YW; Li, WF; Chen, YH |
| 中國醫藥大學 |
2012-02 |
Clinical impact of MDCT before double-balloon enteroscopy for obscure gastrointestinal bleeding
|
顏旭亨(Hsu-Heng Yen)*;陳洋源(Yang-Yuan Chen);(Chia-Wei Yang);(Chi-Kuang Liu);(Maw-Soan Soon) |
| 國立臺灣大學 |
2010 |
Clinical Impact of Methicillin Resistance on Outcome of Patients with Staphylococcus Aureus Infection: A Stratified Analysis According to Underlying Diseases and Sites of Infection in a Large Prospective Cohort
|
劉建衛; 薛博仁; 邱政洵; LIU, JIEN-WEI; HSUEH, PO-REN; CHIU, CHENG-HSUN |
| 臺大學術典藏 |
2018-09-10T08:05:59Z |
Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: A stratified analysis according to underlying diseases and sites of infection in a large prospective cohort
|
Kang, C.-I. and Song, J.-H. and Chung, D.R. and Peck, K.R. and Ko, K.S. and Yeom, J.-S. and Kim, S.-W. and Chang, H.-H. and Kim, Y.-S. and Jung, S.-I. and Son, J.S. and Hsueh, P.-R. and So, T.M.K. and Lalitha, M.K. and Yang, Y. and Huang, S.-G. and Wang, H. and Lu, Q. and Carlos, C.C. and Perera, J.A. and Chiu, C.-H. and Liu, J.-W. and Chongthaleong, A. and Thamlikitkul, V. and Van Pham, H.; 劉建衛;薛博仁;邱政洵; Kang, Cheol-In; Song, Jae-Hoon; Chung, Doo Ryeon; Peck, Kyong Ran; Ko, Kwan Soo; Yeom, Joon-Sup; Kim, Shin-Woo; Chang, Hyun-Ha; Kim, Yeon-Sook; Jung, Sook-In; Son, Jun Seong; Hsueh, Po-Ren; So, Thomas Man-kit; Lalitha, M.K.; Yang, Yonghong; PO-REN HSUEH; Kang, Cheol-In; Song, Jae-Hoon; Chung, Doo Ryeon; Peck, Kyong Ran; Ko, Kwan Soo; Yeom, Joon-Sup; Kim, Shin-Woo; Chang, Hyun-Ha; Kim, Yeon-Sook; Jung, Sook-In; Son, Jun Seong; Hsueh, Po-Ren; So, Thomas Man-kit; Lalitha, M.K.; Yang, Yonghong |
| 臺大學術典藏 |
2020-03-27T05:29:52Z |
Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: A stratified analysis according to underlying diseases and sites of infection in a large prospective cohort
|
Van Pham H.; Thamlikitkul V.; Chongthaleong A.; Liu J.-W.; Chiu C.-H.; Perera J.A.; Carlos C.C.; Lu Q.; Wang H.; Huang S.-G.; Yang Y.; Lalitha M.K.; PO-REN HSUEH; So T.M.K.; Son J.S.; Jung S.-I.; Kim Y.-S.; Chang H.-H.; Kim S.-W.; Yeom J.-S.; Ko K.S.; Peck K.R.; Chung D.R.; Song J.-H.; Kang C.-I.; Van Pham H.;Thamlikitkul V.;Chongthaleong A.;Liu J.-W.;Chiu C.-H.;Perera J.A.;Carlos C.C.;Lu Q.;Wang H.;Huang S.-G.;Yang Y.;Lalitha M.K.;So T.M.K.;PO-REN HSUEH;Son J.S.;Jung S.-I.;Kim Y.-S.;Chang H.-H.;Kim S.-W.;Yeom J.-S.;Ko K.S.;Peck K.R.;Chung D.R.;Song J.-H.;Kang C.-I. |
| 臺大學術典藏 |
2020-12-18T08:38:36Z |
Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: A stratified analysis according to underlying diseases and sites of infection in a large prospective cohort
|
Kang C.-I.;Song J.-H.;Chung D.R.;Peck K.R.;Ko K.S.;Yeom J.-S.;Kim S.-W.;Chang H.-H.;Kim Y.-S.;Jung S.-I.;Son J.S.;Po-Ren Hsueh;So T.M.K.;Lalitha M.K.;Yang Y.;Huang S.-G.;Wang H.;Lu Q.;Carlos C.C.;Perera J.A.;Chiu C.-H.;Liu J.-W.;Chongthaleong A.;Thamlikitkul V.;Van Pham H.; Kang C.-I.; Song J.-H.; Chung D.R.; Peck K.R.; Ko K.S.; Yeom J.-S.; Kim S.-W.; Chang H.-H.; Kim Y.-S.; Jung S.-I.; Son J.S.; PO-REN HSUEH; So T.M.K.; Lalitha M.K.; Yang Y.; Huang S.-G.; Wang H.; Lu Q.; Carlos C.C.; Perera J.A.; Chiu C.-H.; Liu J.-W.; Chongthaleong A.; Thamlikitkul V.; Van Pham H. |
| 國立成功大學 |
2023 |
Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia
|
Yu, C.-H.;Jou, S.-T.;Su, Y.-H.;Coustan-Smith, E.;Wu, G.;Cheng, Cheng C.-N.;Lu, M.-Y.;Lin, K.-H.;Wu, K.-H.;Chen, S.-H.;Huang, F.-L.;Chang, H.-H.;Wang, J.-L.;Yen, H.-J.;Li, M.-J.;Chou, S.-W.;Ho, W.-L.;Liu, Y.-L.;Chang, Chang C.-C.;Lin, Z.-S.;Lin, C.-Y.;Chen, H.-Y.;Ni, Y.-L.;Lin, D.-T.;Lin, S.-W.;Yang, J.J.;Ni, Y.-H.;Pui, C.-H.;Yu, S.-L.;Yang, Yang Y.-L. |
| 國立臺灣大學 |
2013 |
Clinical impact of pre- and post-transplant residual disease status detected by multidimensional flow cytometry in 120 adult patients with acute leukaemia
|
Li, C. C.; Tang, J. L.; Lin, C. T.; Yao, M.; Ko, B. S.; Wu, S. J.; Huang, S. Y.; Liu, J. H.; Chou, W. C.; Hou, H. A.; Tien, H. F.; Loken, M. R.; 姚明; 柯博升; 田蕙芬; 黃聖懿; 吳尚儒; 唐季祿; 周文堅; 侯信安 |
| 國立臺灣大學 |
1998-05-28 |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
Chang, Shan-Chwen; Fang, Chi-Tai; Hsueh, Po-Ren; Liu, Chieh-Ju; Sheng, Wang-Huei; Hsieh, Szu-Min; Hung, Chien-Chin; Chen, Yee-Chun |
| 臺大學術典藏 |
2018-09-10T06:51:59Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
PEI-MING YANG; DING-SHINN CHEN; GUAN-TARN HUANG; JIN-CHUAN SHEU; HSUAN-SHU LEE; Sheu, J.-C.; Chen, D.-S.; Yang, P.-M.; Lee, H.-S.; Huang, G.-T.; Chen, C.-H.; Chen, C.-H.;Huang, G.-T.;Lee, H.-S.;Yang, P.-M.;Chen, D.-S.;Sheu, J.-C. |
| 臺大學術典藏 |
2020-02-10T08:59:34Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
Chen C.-H.;Huang G.-T.;Lee H.-S.;Yang P.-M.;Chen D.-S.;Sheu J.-C.; Chen C.-H.; Huang G.-T.; Lee H.-S.; Yang P.-M.; Chen D.-S.; Sheu J.-C.; HSUAN-SHU LEE |
| 臺大學術典藏 |
2021-02-02T06:41:23Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
Chen C.-H.; Huang G.-T.; Lee, Hsuan-Shu; Yang P.-M.; Chen D.-S.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:48Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
CHIEN-HUNG CHEN; Huang G.-T.; Lee H.-S.; Yang P.-M.; Chen D.-S.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-22T05:34:44Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
CHIEN-HUNG CHEN; Huang G.-T.; Lee H.-S.; Yang P.-M.; Chen D.-S.; Sheu J.-C. |
| 臺大學術典藏 |
2021-04-22T06:56:57Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
Chen C.-H.; Huang G.-T.; Lee H.-S.; PEI-MING YANG; Chen D.-S.; Sheu J.-C. |
| 臺大學術典藏 |
2022-09-14T01:30:13Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
CHIEN-HUNG CHEN; Huang G.-T.; Lee H.-S.; Yang P.-M.; Chen D.-S.; Sheu J.-C. |
| 嘉南藥理大學 |
2018-12 |
Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia
|
Wang, Jiun-Ling; Lee, Ching-Chi; Lee, Chung-Hsun; Lee, Nan-Yao; Hsieh, Chih-Chia; Hung, Yuan-Pin; Tang, Hung-Jen; Ko, Wen-Chien |
| 國立成功大學 |
2018-12 |
Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia
|
Wang;Jiun-Ling;Lee;Ching-Chi;Lee;Chung-Hsun;Lee;Nan-Yao;Hsieh;Chih-Chia;Hung;Yuan-Pin;Tang;Hung-Jen;Ko;Wen-Chien |
| 國立成功大學 |
2023-12 |
Clinical impact of the combination of rapid species identification and antifungal stewardship intervention in adults with candidemia
|
Jan;Hao-En;Lo;Ching-Lung;Lee;Jen-Chieh;Li;-Chi, Ming;Lin;Wen-Liang;Ko;Wen-Chien;Lee;Nan-Yao |
| 中國醫藥大學 |
2009-06-27 |
Clinical impact of UDS for pelvic reconstructive surgery
|
鄒頡龍(Chieh-Lung Chou) |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
MENG RUI LEE;Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee;JEN-CHUNG KO; JEN-CHUNG KO; Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee; MENG RUI LEE |
| 臺大學術典藏 |
2020-08-13T05:23:57Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee M.-R.; Lee L.-N.; Ko J.-C.; Lee S.-W.; JANN-YUAN WANG; Lee C.-H.; Lee M.-R.;Lee C.-H.;Jann-Yuan Wang;Lee S.-W.;Ko J.-C.;Lee L.-N. |
| 臺大學術典藏 |
2020-03-31T08:54:25Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
LI-NA LEE; Ko J.-C.; Lee S.-W.; Wang J.-Y.; Lee C.-H.; Lee M.-R.; Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Ko J.-C.;Li-Na Lee |
| 臺大學術典藏 |
2021-01-08T01:57:12Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee L.-N.; MENG-RUI LEE; Lee C.-H.; Wang J.-Y.; Lee S.-W.; Ko J.-C. |
| 臺大學術典藏 |
2021-03-11T07:58:26Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee M.-R.; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N. |
| 臺大學術典藏 |
2021-03-11T08:29:31Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee M.-R.; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N. |
| 臺大學術典藏 |
2021-03-11T08:34:17Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N. |
| 臺大學術典藏 |
2021-09-17T02:50:54Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
MENG-RUI LEE; Lee C.-H.; Wang J.-Y.; Lee S.-W.; Ko J.-C.; Lee L.-N. |
| 臺大學術典藏 |
2021-10-04T07:15:39Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee M.-R.; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N. |
